Syncona Portfolio Ltd

In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 6, 2025), Syncona Portfolio Ltd reported 3 stock positions worth $53.0 million. Its top holding was Autolus Therapeutics (AUTL) at 73.8% of the portfolio, followed by Achilles Therapeutics PL-ADR (ACHL, 23.9%) and Century Therapeutics (IPSC, 2.3%). Compared with Q3 2024, it reduced 1. The biggest sale was Autolus Therapeutics (AUTL, shares −10%).

Most Recent 13F
Q2 2026
Location
St Peter Port, Guernsey, X0
CIK
0001725042
Portfolio Value
$53.0M (Q4 2024)
SEC Filing
0000950123-25-001070 ↗ filed Feb 6, 2025

Holdings Value

0$50.0M$100.0M$150.0M$200.0M Q1 2024: $150.1M Q1 2024 Q2 2024: $85.9M Q2 2024 Q3 2024: $80.7M Q3 2024 Q4 2024: $53.0M $53.0M Q4 2024 Q1 2025: $26.4M Q1 2025 Q2 2025: $38.6M Q2 2025 Q3 2025: $27.7M Q3 2025 Q4 2025: $34.3M Q4 2025 Q1 2026: $25.7M Q1 2026 Q2 2026: $26.6M Q2 2026

Holdings 3 stocks · $53.0M
AUTL Autolus Therapeutics PLC 73.83% 16,640,720 $39.1M Reduce -10.3%
ACHL Achilles Therapeutics PL-ADR 23.86% 11,086,909 $12.6M No change
IPSC Century Therapeutics Inc. 2.31% 1,213,056 $1.2M No change

Portfolio Sells Q3 2024 → Q4 2024
AUTL Autolus Therapeutics PLC Reduce -10.3% 73.83% −9.60

Portfolio Buys Q3 2024 → Q4 2024
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 1$26.6MAUTL
Q1 2026 2$25.7MAUTL, IPSC
Q4 2025 2$34.3MAUTL, IPSC
Q3 2025 2$27.7MAUTL, IPSC
Q2 2025 2$38.6MAUTL, IPSC
Q1 2025 2$26.4MAUTL, IPSC
Q4 2024 3$53.0MAUTL, ACHL, IPSC
Q3 2024 3$80.7MAUTL, ACHL, IPSC
Q2 2024 3$85.9MAUTL, ACHL, IPSC
Q1 2024 2$150.1MAUTL, ACHL